Abstract
241Am(III)-citrate was injected intraperitoneally into rats and Syrian hamsters. Its metabolic behaviour in both species shows some differences: a higher deposition of 241Am in the skeleton and kidneys as well as a longer residence time in the liver of the hamster. Ca-DTPA is more effective in mobilizing 241Am from the rat liver whereas the removal from the kidneys is more pronounced in the hamster. As to the skeletal burden, the chelate was equally effective in both species. The data are discussed from the theoretical point of view.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Nuclear Medicine and Biology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
